Results

Total Results: 463 records

Showing results for "renal".

321. Disposition of Comments_Comparative Effectiveness Review No. 268: Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Health and Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-268-racial-disparities-health-healthcare-disposition-comments.pdf
     December 08, 2023 - and Measured Glomerular Filtration Rates and the CKD-EPI Equation Race Coefficient in the Chronic Renal … deemed ineligible to receive cisplatin after the removal of the race coefficient because their revised renal

322. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Administration (FDA) has labeled peginterferon alfa-2a for use in hepatitis, off-label uses include renal

323. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
     August 22, 2008 - growth hormone deficiency, idiopathic short stature, Turner syndrome, Prader-Willi Syndrome, chronic renal

324. Appendixes A-E (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-appendixes.pdf
     January 01, 2024 - Sex: Female 67.88% Comorbidities: Chronic pulmonary disease: 44%, Congestive heart failure: 19.7%, Renal … Cerebrovascular disease: 40%, Dementia: 23.2%, Malignancy: 25%, Peripheral vascular disease: 28%, Renal … other dementias: 10.9%, Heart disease: 6.5%, Chronic obstructive pulmonary disease and asthma: 6.5%, Renal … other dementias: 10.9%, Heart disease: 6.5%, Chronic obstructive pulmonary disease and asthma: 6.5%, Renal

325. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research-protocol
     December 08, 2010 - contrast agent used during the procedure to visualize the coronary arteries may cause anaphylaxis or renal

326. skin-cancer-protocol-160810 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
     August 10, 2016 - limited life expectancy (e.g., the very elderly, those with terminal cancer, those with end stage renal

327. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
     September 01, 2011 - basal amount of drug without pharmacologic consultation regarding volume distribution, body mass and renal

328. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
     September 01, 2008 - All trials either excluded patients with cardiac, renal, or hepatic disease or did not report whether

329. Strategies for Patient, Family and Caregiver Engagement: Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-family-engagement-protocol.pdf
     December 31, 2019 - Abbreviations: DM=diabetes, HTN=hypertension, IT=information technology, ER=emergency room; ESRD=end stage renal

330. Methods Research Report - Framework for Determining Research Gaps During Systematic Review: Evaluation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-gaps_research.pdf
     February 01, 2013 - to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal

331. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
     August 27, 2012 - The gain for going from five months to ten months in progression free survival in renal cell carcinoma … specific question for you, Reed, is how do you manage to get patient input on things like treatment for renal

332. Pressure-Ulcer-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
     May 01, 2013 - ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stage renal … ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stage renal

333. Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stent-clopidogrel-practice/research
     March 31, 2009 - conditions (Charlson Index, history of chronic obstructive pulmonary disease, connective tissue disease, renal

334. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal

335. Mass-Casualty-Events-Scarce-Resources Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mass-casualty-events-scarce-resources_executive.pdf
     June 01, 2012 - available resources Medical interventions (2 studies) • Medical interventions for the prevention of acute renal

336. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - adults as well as in patients with advanced cancer and a variety of other comorbidities, including renal

337. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - contrast agent used during the procedure to visualize the coronary arteries may cause anaphylaxis or renal

338. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - literature is deficient in studies enrolling people with varying levels of underlying cardiovascular and renal

339. Interventional Treatments for Acute and Chronic Pain: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/interventional-treatments-pain/protocol
     December 17, 2020 - defined as persons enrolled in Medicare, age >55 years, or persons with disability (including end-stage renal

340. Treatments for Acute Pain: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/treatments-acute-pain/protocol
     January 02, 2020 - efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal